MCK McKesson Corporation
Data as of close
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
McKesson Corporation (MCK) is an industrial company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $116.6 billion. Shares last traded at $1000.35, near their 52-week high. Over the past year the stock is up 23.3%. MCK trades at a price-to-earnings ratio of 25.40, above the Wholesale-Drugs, Proprietaries & Druggists' Sundries median of 25.09. Net profit margin is 1.1%, above the peer median of 0.7%. Revenue grew 12.4% year over year. The shares yield 0.3% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
MCK Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2026-03-31 | $381M | $3.07 | 8% |
| 2025-03-31 | $345M | $2.69 | 10% |
| 2024-03-31 | $314M | $2.34 | 10% |
| 2023-03-31 | $292M | $2.05 | 8% |
| 2022-03-31 | $277M | $1.80 | 25% |
| 2021-03-31 | $276M | $1.72 | — |
| 2020-03-31 | $294M | $1.62 | 33% |
| 2019-03-31 | $292M | $1.48 | 859% |
| 2018-03-31 | $262M | $1.25 | 391% |
| 2017-03-31 | $253M | $1.13 | 5% |
| 2016-03-31 | $244M | $1.05 | 11% |
| 2015-03-31 | $227M | $0.97 | 15% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2027 | $5.15 | 2026-08-05 |
| Q4 2026 (derived) | $13.62 | 2026-05-08 |
| FY 2026 | $38.38 | 2026-05-08 |
| Q3 2026 | $9.59 | 2026-02-04 |
| Q2 2026 | $8.92 | 2025-11-06 |
| Q1 2026 | $6.25 | 2025-08-06 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
MCK vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Data as of close
| MCK | McKesson Corporation | $116.6B | 25.40 | 0.28 | 1.1% | +0.16% |
| COR | Cencora | $65.1B | 24.79 | 0.20 | 0.8% | +0.90% |
| CAH | Cardinal Health | $58.8B | 35.40 | 0.24 | 0.7% | -0.55% |
| HLF | Herbalife Ltd. | $1.5B | 8.40 | 0.29 | 3.4% | +8.36% |
| NUS | NU SKIN ENTERPRISES, INC. | $228M | — | 0.17 | -15.7% | -1.88% |
| COSM | Cosmos Health Inc. | $30M | — | 0.41 | -33.1% | -2.07% |
| ESYN | HWH International Inc. | $13M | — | — | — | -1.49% |
| MEDS | DataMeds AI, Inc. | $5M | — | — | — | -4.49% |
| HKPD | Cellyan Biotechnology Co., Ltd | $1M | — | — | — | -2.16% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.